Status:
COMPLETED
Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients
Lead Sponsor:
Kuopio University Hospital
Conditions:
Sepsis
Eligibility:
All Genders
18-70 years
Brief Summary
The aim of this study is to find out whether inflammation markers including cardiac markers have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological patients.
Detailed Description
Adult AML and ASCT patients with neutropenic fever. Observation of possible progress to severe sepsis or septic shock. Blood sample collection on days 0-3 (from the beginning of neutropenic fever).
Eligibility Criteria
Inclusion
- diagnosis: acute myeloid leukaemia
- age under 70 years
- neutropenic fever
Exclusion
- age above 70 years
- no neutropenic fever
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
273 Patients enrolled
Trial Details
Trial ID
NCT00781040
Start Date
December 1 2006
End Date
January 1 2019
Last Update
March 1 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kuopio University Hospital
Kuopio, Finland, 70211
2
Kuopio University Hospital
Kuopio, Finland